AUTUMN ALLGOOD: Open Payments
NPI 1932824950 · KENNETT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 20 payments from 7 companies in 2025. Trend: 2023 $435 · 2024 $307 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $137 |
| Viatris Specialty LLC | 3 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Lilly USA, LLC | 2 | $33 |
| Amgen Inc. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: Ozempic, YUPELRI, GEMTESA, BREZTRI, MOUNJARO, OTEZLA, GARDASIL 9, ZEPBOUND.
Industry payments across MO — which companies pay providers there.
